18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

AST 0 3 25 28 B-clinical_variable
/ 3 4 28 29 I-clinical_variable
ALT 4 7 29 32 I-clinical_variable
≤ 8 9 33 34 O
5 10 11 35 36 B-upper_bound
times 12 17 37 42 I-upper_bound
the 18 21 43 46 I-upper_bound
upper 22 27 47 52 I-upper_bound
limit 28 33 53 58 I-upper_bound
of 34 36 59 61 I-upper_bound
normal 37 43 62 68 I-upper_bound
range 44 49 69 74 I-upper_bound

Absolute 0 8 75 83 B-clinical_variable
neutrophil 9 19 84 94 I-clinical_variable
count 20 25 95 100 I-clinical_variable
> 26 27 101 102 O
1500 28 32 103 107 B-lower_bound
mm3 33 36 108 111 I-lower_bound

Active 0 6 112 118 O
clinically 7 17 119 129 O
serious 18 25 130 137 O
infection 26 35 138 147 B-chronic_disease
> 36 37 148 149 O
CTCAE 38 43 150 155 O
( 44 45 156 157 O
version 45 52 157 164 O
4.03 53 57 165 169 O
) 57 58 169 170 O
Grade 59 64 171 176 O
2 65 66 177 178 O

Allergy 0 7 179 186 O
or 8 10 187 189 O
intolerance 11 22 190 201 O
to 23 25 202 204 O
dornase 26 33 205 212 B-allergy_name
alfa 34 38 213 217 I-allergy_name

At 0 2 218 220 O
least 3 8 221 226 O
2 9 10 227 228 B-lower_bound
days 11 15 229 233 I-lower_bound
from 16 20 234 238 O
administration 21 35 239 253 O
of 36 38 254 256 O
chemotherapy 39 51 257 269 B-treatment

At 0 2 270 272 O
least 3 8 273 278 O
7 9 10 279 280 B-lower_bound
days 11 15 281 285 I-lower_bound
from 16 20 286 290 O
prior 21 26 291 296 B-treatment
major 27 32 297 302 I-treatment
surgery 33 40 303 310 I-treatment

Concurrent 0 10 311 321 O
severe 11 17 322 328 B-chronic_disease
illness 18 25 329 336 I-chronic_disease
such 26 30 337 341 O
as 31 33 342 344 O
active 34 40 345 351 B-chronic_disease
infection 41 50 352 361 I-chronic_disease
, 50 51 361 362 O
or 52 54 363 365 O
psychiatric 55 66 366 377 B-chronic_disease
illness 67 74 378 385 I-chronic_disease
/ 74 75 385 386 I-chronic_disease
social 75 81 386 392 I-chronic_disease
situations 82 92 393 403 I-chronic_disease
that 93 97 404 408 O
would 98 103 409 414 O
limit 104 109 415 420 O
safety 110 116 421 427 O
and 117 120 428 431 O
compliance 121 131 432 442 O
with 132 136 443 447 O
study 137 142 448 453 O
requirements 143 155 454 466 O

Eastern 0 7 467 474 B-clinical_variable
Cooperative 8 19 475 486 I-clinical_variable
Oncology 20 28 487 495 I-clinical_variable
Group 29 34 496 501 I-clinical_variable
( 35 36 502 503 I-clinical_variable
ECOG 36 40 503 507 I-clinical_variable
) 40 41 507 508 I-clinical_variable
performance 42 53 509 520 I-clinical_variable
status 54 60 521 527 I-clinical_variable
score 61 66 528 533 I-clinical_variable
0 67 68 534 535 B-lower_bound
- 68 69 535 536 O
2 69 70 536 537 B-upper_bound

Expected 0 8 538 546 O
survival 9 17 547 555 O
less 18 22 556 560 O
than 23 27 561 565 O
six 28 31 566 569 B-upper_bound
weeks 32 37 570 575 I-upper_bound

High 0 4 576 580 O
- 4 5 580 581 O
risk 5 9 581 585 O
for 10 13 586 589 O
systemic 14 22 590 598 B-chronic_disease
bleeding 23 31 599 607 I-chronic_disease

Life 0 4 608 612 B-clinical_variable
expectancy 5 15 613 623 I-clinical_variable
≥ 16 17 624 625 O
6 18 19 626 627 B-lower_bound
weeks 20 25 628 633 I-lower_bound

Major 0 5 634 639 B-chronic_disease
hemorrhage 6 16 640 650 I-chronic_disease
, 16 17 650 651 O
coincidental 18 30 652 664 O
stroke 31 37 665 671 B-chronic_disease
, 37 38 671 672 O
or 39 41 673 675 O
major 42 47 676 681 B-chronic_disease
trauma 48 54 682 688 I-chronic_disease

Major 0 5 689 694 B-treatment
surgery 6 13 695 702 I-treatment
, 13 14 702 703 O
open 15 19 704 708 B-treatment
biopsy 20 26 709 715 I-treatment
or 27 29 716 718 O
significant 30 41 719 730 O
traumatic 42 51 731 740 B-chronic_disease
injury 52 58 741 747 I-chronic_disease
within 59 65 748 754 O
seven 66 71 755 760 B-upper_bound
( 72 73 761 762 I-upper_bound
7 73 74 762 763 I-upper_bound
) 74 75 763 764 I-upper_bound
days 76 80 765 769 I-upper_bound
of 81 83 770 772 O
first 84 89 773 778 O
study 90 95 779 784 O
drug 96 100 785 789 O
-- 100 102 789 791 O
including 102 111 791 800 O
neurosurgery 112 124 801 813 O

Patients 0 8 814 822 O
who 9 12 823 826 O
are 13 16 827 830 B-pregnancy
pregnant 17 25 831 839 I-pregnancy
or 26 28 840 842 O
lactating 29 38 843 852 O
( 39 40 853 854 O
females 40 47 854 861 B-gender
of 48 50 862 864 O
childbearing 51 63 865 877 O
potential 64 73 878 887 O
must 74 78 888 892 O
have 79 83 893 897 O
a 84 85 898 899 O
negative 86 94 900 908 B-pregnancy
pregnancy 95 104 909 918 I-pregnancy
test 105 109 919 923 O
prior 110 115 924 929 O
to 116 118 930 932 O
participation 119 132 933 946 O
in 133 135 947 949 O
this 136 140 950 954 O
study 141 146 955 960 O
) 146 147 960 961 O

Presence 0 8 962 970 O
of 9 11 971 973 O
any 12 15 974 977 O
intracranial 16 28 978 990 B-cancer
mass 29 33 991 995 I-cancer

Prior 0 5 996 1001 B-treatment
treatment 6 15 1002 1011 I-treatment
with 16 20 1012 1016 O
intrapleural 21 33 1017 1029 B-treatment
fibrinolytic 34 46 1030 1042 I-treatment
agents 47 53 1043 1049 O

Serious 0 7 1050 1057 O
non 8 11 1058 1061 B-chronic_disease
- 11 12 1061 1062 I-chronic_disease
healing 12 19 1062 1069 I-chronic_disease
wound 20 25 1070 1075 I-chronic_disease
, 25 26 1075 1076 O
ulcer 27 32 1077 1082 B-chronic_disease
, 32 33 1082 1083 O
or 34 36 1084 1086 O
bone 37 41 1087 1091 B-chronic_disease
fracture 42 50 1092 1100 I-chronic_disease

Serum 0 5 1101 1106 B-clinical_variable
creatinine 6 16 1107 1117 I-clinical_variable
≤2.0 17 21 1118 1122 O
times 22 27 1123 1128 I-upper_bound
the 28 31 1129 1132 I-upper_bound
upper 32 37 1133 1138 I-upper_bound
limit 38 43 1139 1144 I-upper_bound
of 44 46 1145 1147 I-upper_bound
the 47 50 1148 1151 I-upper_bound
normal 51 57 1152 1158 I-upper_bound
range 58 63 1159 1164 I-upper_bound

Traumatic 0 9 1165 1174 B-chronic_disease
hemorrhagic 10 21 1175 1186 I-chronic_disease
pleural 22 29 1187 1194 I-chronic_disease
effusion 30 38 1195 1203 I-chronic_disease

Women 0 5 1204 1209 B-gender
of 6 8 1210 1212 O
child 9 14 1213 1218 O
- 14 15 1218 1219 O
bearing 15 22 1219 1226 O
potential 23 32 1227 1236 O
( 33 34 1237 1238 O
i.e. 34 38 1238 1242 O
, 38 39 1242 1243 O
women 40 45 1244 1249 B-gender
who 46 49 1250 1253 O
are 50 53 1254 1257 O
pre 54 57 1258 1261 O
- 57 58 1261 1262 O
menopausal 58 68 1262 1272 O
or 69 71 1273 1275 O
not 72 75 1276 1279 O
surgically 76 86 1280 1290 O
sterile 87 94 1291 1298 O
) 94 95 1298 1299 O
must 96 100 1300 1304 O
be 101 103 1305 1307 O
willing 104 111 1308 1315 B-contraception_consent
to 112 114 1316 1318 I-contraception_consent
use 115 118 1319 1322 I-contraception_consent
an 119 121 1323 1325 I-contraception_consent
acceptable 122 132 1326 1336 I-contraception_consent
contraceptive 133 146 1337 1350 I-contraception_consent
method 147 153 1351 1357 I-contraception_consent
( 154 155 1358 1359 O
abstinence 155 165 1359 1369 B-contraception_consent
, 165 166 1369 1370 O
oral 167 171 1371 1375 B-contraception_consent
contraceptive 172 185 1376 1389 I-contraception_consent
or 186 188 1390 1392 O
double 189 195 1393 1399 B-contraception_consent
barrier 196 203 1400 1407 I-contraception_consent
method 204 210 1408 1414 I-contraception_consent
) 210 211 1414 1415 O
for 212 215 1416 1419 O
the 216 219 1420 1423 O
duration 220 228 1424 1432 O
of 229 231 1433 1435 O
the 232 235 1436 1439 O
study 236 241 1440 1445 O
and 242 245 1446 1449 O
for 246 249 1450 1453 O
30 250 252 1454 1456 B-upper_bound
days 253 257 1457 1461 I-upper_bound
following 258 267 1462 1471 O
the 268 271 1472 1475 O
last 272 276 1476 1480 O
dose 277 281 1481 1485 O
of 282 284 1486 1488 O
study 285 290 1489 1494 B-treatment
drug 291 295 1495 1499 I-treatment

hemoglobin 0 10 1500 1510 B-clinical_variable
≥ 11 12 1511 1512 O
8.0 13 16 1513 1516 B-lower_bound
g 17 18 1517 1518 I-lower_bound
/ 18 19 1518 1519 I-lower_bound
dL 19 21 1519 1521 I-lower_bound

must 0 4 1522 1526 O
have 5 9 1527 1531 O
a 10 11 1532 1533 O
negative 12 20 1534 1542 B-pregnancy
urine 21 26 1543 1548 I-pregnancy
or 27 29 1549 1551 I-pregnancy
serum 30 35 1552 1557 I-pregnancy
pregnancy 36 45 1558 1567 I-pregnancy
test 46 50 1568 1572 O
within 51 57 1573 1579 O
2 58 59 1580 1581 B-upper_bound
weeks 60 65 1582 1587 I-upper_bound
prior 66 71 1588 1593 I-upper_bound
to 72 74 1594 1596 O
beginning 75 84 1597 1606 O
treatment 85 94 1607 1616 B-treatment
on 95 97 1617 1619 O
this 98 102 1620 1624 O
trial 103 108 1625 1630 O

platelet 0 8 1631 1639 B-clinical_variable
count 9 14 1640 1645 I-clinical_variable
≥ 15 16 1646 1647 O
100×109 17 24 1648 1655 B-lower_bound
L 25 26 1656 1657 I-lower_bound

total 0 5 1658 1663 O
bilirubin 6 15 1664 1673 B-clinical_variable
≤ 16 17 1674 1675 O
2.5 18 21 1676 1679 B-upper_bound
mg 22 24 1680 1682 I-upper_bound
/ 24 25 1682 1683 I-upper_bound
dL 25 27 1683 1685 I-upper_bound

